Synergistic and additive interactions of the cannabinoid agonist CP55,940 with μ opioid receptor and α 2-adrenoceptor agonists in acute pain models in mice

Abstract

Cannabinoid receptor agonists elicit analgesic effects in acute and chronic pain states via spinal and supraspinal pathways. We investigated whether the combination of a cannabinoid agonist with other classes of antinociceptive drugs exerted supra-additive (synergistic) or additive effects in acute pain models in mice. The interactions between the cannabinoid agonist CP55,940, α 2-adrenoceptor agonist dexmedetomidine and μ-opioid receptor agonist morphine were evaluated by isobolographic analysis of antinociception in hot plate (55°C) and tail flick assays in conscious male Swiss mice. Drug interactions were examined by administering fixed-ratio combinations of agonists (s.c.) in 1: 1, 3: 1 ..